Products

What will AGI do for Betahistine hydrochloride?

This classification denotes a vasodilating agent with the molecular formula C8H12N2.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 49K58SMZ7U, chemically known as 2-pyridineethanamine, n-methyl-, dihydrochloride but more generally known as betahistine dihydrochloride, which bears US NIH Compound Identifier 68643. The base compound, Betahistine, most often comes in base, dihydrochloride, hydrochloride, and mesylate forms. European Medicines Agency schedules Betahistine dihydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00772MIG. Most nations, for tariff and trade purposes, schedule betahistine hydrochloride under HS 29333999 and SITC 51574. As of Q4 2014, BETAHISTINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Betahistine hydrochloride bears US NLM identifiers UMLS ID C0282071 and NCI Concept Code C73794. SMILES: CNCCC1CCCCN1.CL.CL.

How AGI delivers it

Four ways AGI delivers for Betahistine hydrochloride

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Betahistine hydrochloride, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Betahistine hydrochloride, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Betahistine hydrochloride connects

measured by

  • Assay Puritymodel
  • Chloride Contentmodel
  • Loss On Dryingmodel